Publications

Research outputs, reports, policy briefs and knowledge products from KIU scholars and partners.

Knowledge Outputs

Featured publications

Publication records can include DOI links, downloads, authors, abstracts and indexing data.

Reset
5,279 results found Records are sourced from the KIU Publications module.
2025 Faculty of Clinical Medicine and Dentistry

Nanotechnology and Gut Microbiome Modulation in Obesity

Winniefred Nankya

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 17-23

The gut microbiome plays a pivotal role in obesity pathogenesis by influencing nutrient absorption, energy metabolism, inflammation, and host signaling pathways. Dysbiosis imbalances in microbial composition has been linked to weight gain, insulin resistance,...

2025 School of Pharmacy

Nanoparticle-Encapsulated Artemisinin Derivatives for Plasmodium falciparum: Comparative Efficacy, Pharmacokinetics, and Resistance Prevention

Mercy Latricia

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 12-16

Artemisinin derivatives are the backbone of current malaria therapy, yet Plasmodium falciparum resistance threatens global control efforts. Poor solubility, short half-life, and suboptimal tissue distribution limit their efficacy. Nanoparticle encapsulation o...

2025 School of Pharmacy

Nanoparticle-Enabled Insulin Delivery Systems for Optimizing Glycemic Control in Diabetes Mellitus

Nasira A. Sitar

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 5-11

Diabetes mellitus affects over 537 million adults worldwide, with inadequate glycemic control contributing to significant morbidity and mortality despite advances in insulin therapy. Conventional insulin delivery systems faced limitations including frequent i...

2025 School of Pharmacy

Nanoparticle-Based Insulin Delivery Systems: Overcoming Barriers in Obesity-Associated Diabetes

Abaho Areeba Fortunate

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 128-135

Obesity profoundly alters insulin pharmacokinetics and pharmacodynamics through expanded and inflamed adipose depots, altered subcutaneous tissue architecture, and systemic low-grade inflammation, all of which complicate insulin replacement therapy. Nanoparti...

2025 School of Pharmacy

Nanoparticle-Based Drug Delivery Systems in Cancer Therapy: Enhancing Targeted Treatment and Reducing Toxicity

Muhindo Anitah

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 119-127

Cancer remains one of the leading causes of mortality worldwide, posing significant challenges to conventional therapeutic approaches due to poor targeting, systemic toxicity, and multidrug resistance. Nanoparticle-based drug delivery systems (NDDSs) have eme...

2025 School of Pharmacy

Nanoparticle-Based Antiretroviral Delivery Systems to Overcome Drug Resistance and Improve HIV Management

Masika Anna Mahinda

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 1-4

Antiretroviral therapy (ART) had transformed HIV infection into a chronic, manageable condition. However, drug resistance, poor adherence, and limited drug penetration into viral reservoirs hinder long-term viral suppression and complicate cure strategies. No...

2025 School of Pharmacy

Nanoparticle-Based Antimalarials versus Conventional Therapy: Resistance Suppression in Plasmodium falciparum Clinical Studies

Muhindo Edgar

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 136-139

Malaria caused by Plasmodium falciparum remains one of the most pressing public health challenges in sub-Saharan Africa and Southeast Asia. Artemisinin-based combination therapies (ACTs) have reduced mortality substantially over the past two decades, yet part...

2025 School of Pharmacy

Nanoparticle Based Gene Therapy for Obesity and Metabolic Syndrome

Mukisa Ian Mugaiga

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 112-118

Obesity and metabolic syndrome are multifactorial conditions characterized by dysregulated energy metabolism, insulin resistance, chronic inflammation, and increased risk of diabetes and cardiovascular disease. Conventional pharmacological treatments often pr...

2025 School of Pharmacy

Nanomedicine in Brown and Beige Fat Activation: A Novel Strategy for Combating Obesity-Driven Diabetes

Mutebi Mark

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 105-111

Obesity-driven type 2 diabetes (T2D) remains a major global health challenge. Activation or recruitment of thermogenic adipocytes classical brown adipose tissue (BAT) and inducible beige adipocytes within white adipose tissue (WAT) increases energy expenditur...

2025 School of Pharmacy

Nanomedicine for Targeted Delivery of Antidiabetic Drugs

Ernest Nsubuga

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 96-104

Diabetes mellitus remains one of the most pressing global health concerns, with type 1 and type 2 diabetes affecting millions of individuals worldwide. Conventional drug delivery methods often face challenges such as poor bioavailability, systemic side effect...